| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454517 | Lung Cancer | 2016 | 6 Pages |
Abstract
Over 20 years, biennial LDCT screening for lung cancer appears to provide similar benefit in terms of QALYs gained to annual screening and is more cost-effective. Further study of biennial screening should be undertaken in population screening programs. A smoking cessation program should be integrated into either screening strategy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
John R. MD, FRCPC, William M. BM, Anthony B. MD, FRCPC, Natalie R. MA, Saima MBBS, MPH, Michael C. PhD, William K. MD, FRCPC,